China Biologic Produ
(CBPO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 118,205 | 219,337 | 216,445 | 223,244 | 197,357 |
| Marketable Securities | 248,434 | 22,895 | N/A | N/A | N/A |
| Receivables | 96,279 | 77,267 | 74,159 | 61,146 | 51,648 |
| Inventories | 231,526 | 209,571 | 198,608 | 183,259 | 166,381 |
| Other current assets | 47,709 | 45,912 | 0 | 0 | 0 |
| TOTAL | $765,978 | $593,122 | $507,154 | $485,293 | $433,118 |
| Non-Current Assets | |||||
| PPE Net | 192,321 | 166,813 | 155,135 | 145,411 | 138,038 |
| Investments And Advances | 16,569 | 14,904 | 14,165 | 12,780 | 11,583 |
| Intangibles | 421,455 | 25,390 | 24,608 | 24,181 | 23,363 |
| Other Non-Current Assets | 10,165 | 8,830 | 52,796 | 50,540 | 49,320 |
| TOTAL | $640,509 | $215,936 | $246,704 | $232,911 | $222,304 |
| Total Assets | $1,406,487 | $809,057 | $753,859 | $718,204 | $655,422 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | 14,466 | 8,696 |
| Accounts payable and accrued liabilities | 100,273 | 83,377 | 68,058 | 70,437 | 66,219 |
| TOTAL | $117,576 | $97,635 | $78,639 | $93,094 | $84,306 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 47,677 | 41,078 | 3,007 | 2,781 | 2,256 |
| TOTAL | $57,128 | $47,097 | $10,154 | $10,186 | $10,258 |
| Total Liabilities | $174,704 | $144,732 | $88,792 | $103,280 | $94,564 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | N/A | 27,612 | 27,609 | 27,238 | 27,201 |
| Common Shares | 4 | 3 | 3 | 3 | 3 |
| Retained earnings | 538,012 | 506,426 | 531,071 | 499,506 | 468,475 |
| Other shareholders' equity | 165,300 | 73,665 | 58,980 | 49,248 | 34,749 |
| TOTAL | $1,231,783 | $664,325 | $665,066 | $614,924 | $560,858 |
| Total Liabilities And Equity | $1,406,487 | $809,057 | $753,859 | $718,204 | $655,422 |